<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/25/nu-skin-enterprises-inc-nysenus-declares-quarterly-dividend-of-0-37.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-25T08:20:41+00:00"/>
    <meta property="og:title" content="Nu Skin Enterprises, Inc. (NYSE:NUS) Declares Quarterly Dividend of $0.37"/>
    <meta property="og:description" content="Nu Skin Enterprises, Inc. (NYSE:NUS) announced a quarterly dividend on Tuesday, November 5th, Zacks reports. Stockholders of record on Friday, November 29th will be paid a dividend of 0.37 per share on Wednesday, December 11th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 3.89%. The ex-dividend date of this […]"/>
  </head>
  <body>
    <article>
      <h1>Nu Skin Enterprises, Inc. (NYSE:NUS) Declares Quarterly Dividend of $0.37</h1>
      <address><time datetime="2019-11-25T08:20:41+00:00">25 Nov 2019, 08:20</time> by <a rel="author" href="https://www.thecerbatgem.com/author/teresa" target="_blank">Teresa Graham</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/nu-skin-enterprises-inc-logo.gif"/>
      </figure>
      <p><b>Nu Skin Enterprises, Inc.</b> (NYSE:NUS) announced a quarterly dividend on Tuesday, November 5th, <a href="https://www.zacks.com/">Zacks</a> reports. Stockholders of record on Friday, November 29th will be paid a dividend of 0.37 per share on Wednesday, December 11th. This represents a $1.48 dividend on an annualized basis and a dividend yield of 3.89%. The ex-dividend date of this dividend is Wednesday, November 27th.</p>
      <p>Shares of <a href="https://www.marketbeat.com/stocks/NYSE/NUS/dividend/">NYSE:NUS</a> opened at $38.05 on Monday. The company has a current ratio of 2.01, a quick ratio of 1.24 and a debt-to-equity ratio of 0.50. Nu Skin Enterprises has a 1 year low of $35.03 and a 1 year high of $69.79. The business has a fifty day simple moving average of $42.11 and a 200 day simple moving average of $44.45. The firm has a market cap of $2.10 billion, a price-to-earnings ratio of 10.81, a P/E/G ratio of 1.31 and a beta of 0.75.</p>
      <p>Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Tuesday, November 5th. The company reported $0.79 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.03. The firm had revenue of $590.00 million for the quarter, compared to the consensus estimate of $605.02 million. Nu Skin Enterprises had a net margin of 4.59% and a return on equity of 23.52%. The business’s quarterly revenue was down 13.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.94 earnings per share. On average, sell-side analysts forecast that Nu Skin Enterprises will post 3.11 EPS for the current year.</p>
      <p>In related news, insider Foulis Greg 500,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Wednesday, November 6th. 3.20% of the stock is currently owned by company insiders.</p>
      <p>Several equities analysts have commented on the stock. DA Davidson set a $42.00 target price on shares of Nu Skin Enterprises and gave the stock a “hold” rating in a research report on Friday, October 11th. Pivotal Research reaffirmed a “buy” rating and issued a $70.00 price target on shares of Nu Skin Enterprises in a research report on Wednesday, August 7th. <a href="https://www.americanconsumernews.net/scripts/click.aspx?ValuEngine=1&amp;Symbol=NUS">ValuEngine</a> raised Nu Skin Enterprises from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd. Stifel Nicolaus upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and increased their target price for the company from $38.50 to $45.00 in a research note on Tuesday, October 29th. Finally, Citigroup cut shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating in a research note on Wednesday, November 6th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $50.63.</p>
      <p>
        <b>About Nu Skin Enterprises</b>
      </p>
      <p>Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.</p>
      <p>Featured Story: <a href="https://www.marketbeat.com/financial-terms/what-is-meant-by-holder-of-record/">If I purchase shares through a brokerage account, am I the holder of record?</a></p>
      <figure>
        <img src="https://www.marketbeat.com/scripts/DividendChart.ashx?Prefix=NYSE&amp;Symbol=NUS"/>
      </figure>
    </article>
  </body>
</html>